Damora Therapeutics DMRA
NASDAQ DMRA
$21.71 +0.18 (+0.84%)
At close: Oct 22, 2026 · 4:00 PM EDT

Damora Therapeutics (DMRA) Price to Sales (2021 - 2026)

Updated

Analysis

Damora Therapeutics (DMRA) Price to Sales (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Damora Therapeutics 1.34 Bn 1.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 196.49
Mar 31, 2026 213.62
Dec 31, 2025 27.04
Sep 30, 2025 12.53
Jun 30, 2025 9.07
Mar 31, 2025 6.20
Dec 31, 2024 7.26
Sep 30, 2024 15.94
Jun 30, 2024 250.49
Mar 31, 2024 349.67
Dec 31, 2023 288.95
Sep 30, 2023 298.85
Jun 30, 2023 1,232.72
Mar 31, 2023 1,246.10
Dec 31, 2022 1,131.14
Sep 30, 2022 3,036.94
Jun 30, 2022 5,170.04
Mar 31, 2022 7,805.62
Dec 31, 2021 12,266.56
API Access

Damora Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=DMRA&period=max&api_key=YOUR_API_KEY